|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Properties | ||||||||||||||||||||
| Accumulated depreciation and amortization | ||||||||||||||||||||
| Real Estate Investment Property, Net | ||||||||||||||||||||
| Investment in Unconsolidated Joint Ventures (UJVs) (Notes 2 and 4) | ||||||||||||||||||||
| Cash and cash equivalents (Note 13) | ||||||||||||||||||||
| Restricted cash (Note 13) | ||||||||||||||||||||
| Accounts and notes receivable (Note 1) | ||||||||||||||||||||
| Accounts receivable from related parties | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Deferred charges and other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Notes payable, net (Note 5) | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Distributions in excess of investments in and net income of UJVs (Note 4) | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable Noncontrolling Interest, Equity, Carrying Amount | ||||||||||||||||||||
| Redeemable noncontrolling interests (Note 6) | ||||||||||||||||||||
| Equity (Deficit): | ||||||||||||||||||||
| Series B Non-Participating Convertible Preferred Stock, $0.001 par and liquidation value, 40,000,000 shares authorized, 25,979,064 and 26,398,473 shares issued and outstanding at September 30, 2020 and December 31, 2019 | ||||||||||||||||||||
| Common Stock, $0.01 par value, 250,000,000 shares authorized, 61,723,103 and 61,228,579 shares issued and outstanding at September 30, 2020 and December 31, 2019 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) (Note 12) | ||||||||||||||||||||
| Dividends in excess of net income (Note 7) | ||||||||||||||||||||
| Stockholders' Equity Attributable to Parent | ||||||||||||||||||||
| Noncontrolling interests (Note 6) | ||||||||||||||||||||
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | ||||||||||||||||||||
| Total Liabilities and Equity |
Loading...
